- Sarepta Stock Soars. Why Layoffs and a ‘Black-Box’ Warning Are Good News. Barron’s
- Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting The Boston Globe
- Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg
- Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks BioPharma Dive
- Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning Fierce Biotech
Source link
:max_bytes(150000):strip_icc()/GettyImages-2161750944-df8891b94a9944f88e0d089c6b055a03.jpg "Chip Maker TSMC’s Stock Rises on Upbeat Outlook for Revenue, Strong AI Demand")